ArticleContemporary clinical trials communications2017
Quality of abstracts of randomized control trials in five top pain journals: A systematic survey.
Article in Contemporary clinical trials communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A multiyear systematic survey of the quality of reporting for randomised trials in dentistry, neurology and geriatrics published in journals of Spain and Latin America.BMC medical research methodology · 2021Pooled it
- Article
- Review
- Time to Publication for Randomized Clinical Trials Presented as Abstracts at Three Gastroenterology and Hepatology Conferences in 2017.Gastro hep advances · 2023Article
- Article
- Article
- Evaluation of reporting quality of abstracts of randomized controlled trials regarding patients with COVID-19 using the CONSORT statement for abstracts.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022Article
- Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement.Journal of thrombosis and thrombolysis · 2019Review
- Reporting Quality of Journal Abstracts for Surgical Randomized Controlled Trials Before and After the Implementation of the CONSORT Extension for Abstracts.World journal of surgery · 2019Review
- Reporting quality of randomised controlled trial abstracts presented at the SLEEP Annual Meetings: a cross-sectional study.BMJ open · 2019Article
- A methodological survey on reporting of pilot and feasibility trials for physiotherapy interventions: a study protocol.BMJ open · 2019Article
- The reporting of progression criteria in protocols of pilot trials designed to assess the feasibility of main trials is insufficient: a meta-epidemiological study.Pilot and feasibility studies · 2019Article
- Reporting quality of randomized controlled trial abstracts in the seven highest-ranking anesthesiology journals.Trials · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe reporting quality of abstracts of randomized control trials (RCTs) is inadequate despite the publication of consolidated standards of reporting trials extension for abstracts (CONSORT-A). We compared the reporting quality of abstracts in pain journals before and after the publication of CONSORT-A.
methodsWe searched MEDLINE in April-2016 for RCTs published in five pain journals: Pain, Pain Physician, European Journal of Pain, Clinical Journal of Pain and Pain Practice for pre- and post-CONSORT-A period (2005-2007 and 2013-2015). Data were extracted in duplicate from 250 abstracts for compliance with CONSORT-A, and for items known to affect reporting quality: journal endorsement of CONSORT, number of trial centers, sample-size, type of intervention, industry-sponsorship and significance of results. The primary outcome was mean number of items reported and the secondary outcome was the reporting of each item. We used logistic regression and Poisson regression for analyses.
resultsMost trials were single centric (76%), had sample size <100 (63%), involved pharmacological intervention (59%) and were non-industry funded (70%). The mean number of items reported was better for 2013-2015 (mean difference 0.94; 95% confidence-interval [CI]: 0.50-1.38, p < 0.001). Post-CONSORT-A, trials were more likely to report as randomized in the title (odds ratio (OR) 2.69; 95% CI 1.61-4.49), describe eligibility criteria and settings (OR 2.47; 95% CI 1.35-4.54), provide effect size and precision for primary outcome (OR 2.47; 95% CI 1.19-5.16), inform harms (OR 1.80; 95% CI 1.05-3.07) and report trial registration (OR 5.13; 95% CI 1.44-18.32). Post-CONSORT-A period (incident rate ratio (IRR) 1.15; 95% CI 1.07-1.24), endorsement of CONSORT statement by the journal (IRR 1.08; 95% CI 1.02-1.14), multi-centric studies (IRR 1.14; 95% CI 1.08-1.20), and studies with pharmacological interventions (IRR 1.07; 95% CI 1.02-1.13) were significantly associated with reporting of more items.
conclusionsAbstract reporting for trials in pain literature was better in the post-CONSORT-A period, but there is room for improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.